Amygdalin mediates relieved atherosclerosis in apolipoprotein E deficient mice through the induction of regulatory T cells
- 5 August 2011
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 411 (3), 523-529
- https://doi.org/10.1016/j.bbrc.2011.06.162
Abstract
No abstract availableKeywords
Funding Information
- GuangxiScienceFoundation (09320005)
This publication has 33 references indexed in Scilit:
- Regulatory T-Cell Immunity in AtherosclerosisTrends in Cardiovascular Medicine, 2007
- Role of Naturally Occurring CD4 + CD25 + Regulatory T Cells in Experimental AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Natural regulatory T cells control the development of atherosclerosis in miceNature Medicine, 2006
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Leukocyte-Derived Interleukin 10 Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor Knockout MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Specific abrogation of transforming growth factor-β signaling in T cells alters atherosclerotic lesion size and composition in miceBlood, 2003
- The Role of Interleukin-4 and Interleukin-12 in the Progression of Atherosclerosis in Apolipoprotein E-Deficient MiceThe American Journal of Pathology, 2003
- Innate and acquired immunity in atherogenesisNature Medicine, 2002
- Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor–Deficient Mice by Altering Lymphocyte and Macrophage PhenotypesCirculation Research, 2002
- Inhibition of Transforming Growth Factor-β Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in MiceCirculation Research, 2001